Background In recent years, the field of nanotechnology and nanomedicine has transformed
the pharmaceutical industry with the development of novel drug delivery systems that …

In last two decades, the lipid nanocarriers have been extensively investigated for their drug
targeting efficiency towards the critical areas of the human body like CNS, cardiac region …

The efficacy of current standard chemotherapy is suboptimal due to the poor solubility and
short half-lives of chemotherapeutic agents, as well as their high toxicity and lack of …

Advancements in both material science and bionanotechnology are transforming the health
care sector. To this end, nanoparticles are increasingly used to improve diagnosis …

Cancer is a disease manifested as abnormal cells division without control. If it is not detected
and cured very timely, it can invade other healthy tissues resulting in metastasis …

In the past decade, research in the area of nanodrug delivery has reached a new height with
the advent of lipid based nanodrug delivery systems. Lipids being biocompatible and …

Solid–lipid nanoparticles and nanostructured lipid carriers are delivery systems for the
delivery of drugs and other bioactives used in diagnosis, therapy, and treatment procedures …

Glioblastoma multiforme (GBM) is the most common and malignant type of brain tumor. In
fact, tumor recurrence usually appears a few months after surgical resection and …

NLCs have provoked the incessant impulsion for the development of safe and valuable drug
delivery systems owing to their exceptional physicochemical and then biocompatible …

Lipid nanocarriers are developed as an alternative to polymeric nanoparticles, liposomes
and emulsions. Further, Nanostructured Lipid Nanocarriers are the second generation lipid …